test altFunding OpportunitiesAward ManagementComliance Review and OversightEducation and TrainingTechnology Transfer
Office of Research and Technology Management
Promoting Research, Advancing Scholarship, Fostering Innovation
Identify Funding Oportunities Proposal Development Award Management
Compliance Review and Oversight Education and Training Technology Transfer


Welcome from the Vice President for Research

CWRU researchers are among the most distinguished in the world. We have 16 Nobel Laureates among current and former faculty and alumni, 4 members of the National Academies of Sciences, 7 members of the National Academy of Engineering, and 8 members of the Institute of Medicine. We also partner with artistic and cultural institutions on a broad range of projects that make important scholarly contributions in the humanities and social sciences.

Extraordinary research requires an outstanding infrastructure. Our Office of Research & Technology Management provides support to seek out grant funding, to facilitate industrial sponsorship, and to transfer university technologies to the marketplace. This is a place for people driven to make a difference, and our office exists to help them succeed.

Contact us. We want you to see what our campus can offer.

Dr. Suzanne Rivera


Research Matters

Research Matters

Use the following link in order to view previous editions of Research Matters and Research News and Updates Research Matters Archive .




Latest News

Research Newsletter
May 14, 2015  

NEW Limited Submission: W.M. Keck Foundation Research Program

Key Deadlines: June 15, 2015 (CWRU internal LOI), November 1, 2015 (Sponsor Deadline).

The W.M. Keck Foundation Research Program seeks to benefit humanity by funding fundamental, high-risk research in two specific areas: 1) medical research and 2) science and engineering. Both Senior and Early Career investigators are encouraged to apply. CWRU may submit two proposals per funding cycle: one (1) in Medical Research and one (1) in Science and Engineering Research.

Applicants are encouraged to consult with their Associate Deans for Research prior to internal submission to assure they meet eligibility criteria and their projects meet stated program objectives.

Grants of up to $1 million over 3 years are awarded for projects in science and engineering research and medical research that:

  • Focus on basic, early stage, emerging areas of research, not on clinical or translational research, treatment trials or research for the sole purpose of drug development.
  • Have the potential to develop breakthrough technologies, instrumentation or methodologies.
  • Have few, if any, peer groups pursuing comparable or related work.
  • Have high level of risk due to unconventional approaches, or by challenging the prevailing paradigm.
  • Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem.
  • Fall outside the mission of public funding agencies. Provide specifics. If you've been declined federal funding, provide the documentation stating why, if available.
  • Demonstrate that the W. M. Keck Foundation's support is essential to the project's success.


For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
Limited Submission Reminder: Hartwell Foundation - Individual Biomedical Research Awards

Key Deadlines: June 1, 2015 (CWRU internal letter of intent); June 30, 2015 (CWRU internal application); September 15, 2015 (Sponsor's submission deadline).

Because Case Western Reserve University earned an at-large bid in The Hartwell Foundation's Individual Biomedical Research Awards program, CWRU is eligible to nominate two faculty members for proposal submission this year. Since 2011, five CWRU faculty members have been selected for Hartwell awards.

The foundation funds 12 Hartwell Investigators annually for their innovative, early-stage, cutting-edge biomedical research that has the potential to benefit children in the USA. These awards provide funding to individual researchers in the U.S. for three years, at $100,000 direct cost per year.

Number of Applications Allowed: Two faculty members. For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
Ferring Pharmaceuticals

Ferring Pharmaceuticals is pleased to announce that the Ferring Innovation Grants Portal is now open and accepting applications. The goal of the Ferring Innovation Grants program is to fund projects designed to identify novel drug targets that are:

  • For indications within their core therapeutic areas (Reproductive Health, Urology, Gastroenterology)

  • Addressable with peptides and/or proteins

  • Exploratory, discovery and/or preclinical in nature


The program will provide a limited number of grants in the amount of $50,000. The grants DO NOT carry indirect costs and are not renewable. Funding will not be provided for clinical studies, studies which require collection of patient biopsies or studies to develop small molecules. In all cases the intellectual property rights remain with the applicant.

Application Deadline: July 1st, 2015

For more information visit the Ferring Pharmaceuticals webpage.

 
Purchasing Computing Devices with Federal Funds under the New Uniform Guidance (2 CFR Parts 200.20 and 200.453)

Computing devices are machines used to acquire, store, analyze, process, and publish data and other information electronically and include accessories (or peripherals) for printing, transmitting and receiving, or storing electronic information. Computing devices costing less than $5,000 are not considered equipment and therefore are treated as supplies and materials. Therefore, if a computing device is to be acquired for use in the performance of a federal award, the computing device may be charged to the federal award provided that:

  • it is essential (i.e., necessary) to performing the work under the award, and
  • the cost is allocable and reasonable.
Determining whether a computing device is essential – The Principal Investigator should consider (and document) whether performing the work under the award without the computing device would be difficult and inefficient. An important measure of this is determining (and documenting) whether the anticipated cost of performing the work without the computing device is greater than the combined cost of performing the work plus the cost of acquiring the computing device.

Determining whether a computing device is allocable to a federal award – If a computing device is essential to and will benefit a federal award, it is allocable to that award. The cost may be allocated to a federal award even when its usage is not solely dedicated to it. However, the Principal Investigator should first consider the amount of benefit of the computing device to the project, and the cost should be allocated proportionally with a reasonable cost allocation methodology.

Determining whether the cost of a computing device is reasonable – The Principal Investigator must make an informed, prudent decision, taking into consideration not only the cost, but the utility, quality and value of the device to the project.

If a computing device is not essential to a federal award, it is not allocable (in whole or in part) as a direct cost to that award. In such cases, the computing device is considered to be a “general use” item and must be treated as an indirect cost expense (just like paper, pens and other general use supplies), and charged to an appropriate institutional funding source.

Please remember that all expenses charged to federal awards must conform to the cost principles specified in the OMB Uniform Guidance. Please consult with the Office of Research Administration if you should have any questions about whether you may charge a specific expense to federal funds.

 
NIH Posts Reminder of Its Policy on Application Compliance

The National Institutes of Health (NIH) recently released a notice to remind applicants, both investigators and grants office officials, that to be fair to all concerned the NIH needs to consistently apply standards for application compliance.

In part, the notice states that NIH may withdraw any application identified during the receipt, referral and review process that is not compliant with the instructions in the SF 424 (R&R) Application Guide, the Funding Opportunity Announcement, and relevant NIH Guide Notices.

Examples of reasons an application may be withdrawn for non-compliance include:

  • inclusion of biosketchs that do not conform to the required format
  • applications that do not conform to page limit requirements
  • applications submitted as new but containing elements of a resubmission or renewal application
  • applications submitted after 5 pm local time
Read the full notice at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-095.html.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.